Visit COVID-19 resources

[Skip to Content]

Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab – (Eye Journal AOP)

18 December 2015

This news item is available to RCOphth members only, please log in below to access.

Members Login